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Primordial follicles, each consisting of a central oocyte surrounded by a single layer of supporting granulosa cells 
(GCs) are held in a relative state of developmental arrest until activated to grow1–3. Maintenance and regulation of 
the arrested state is fundamental for ensuring that a steady supply of oocytes is available for ovulation throughout 
the reproductive life time in most mammals4,5; however, the molecular mechanisms that operate to maintain this 
quiescent phenotype are currently unclear.
We recently showed that in the mouse ovary, the TGFβ-mediated transcription factors SMAD2/3 are detect-
able in nuclei of primordial GCs, suggesting that this pathway is active in these cells6. It is well established that 
TGFβ signalling is important for maintaining growth arrest in a range of cell types by directly inhibiting Myc7–9, 
as well as regulating the expression of other cell cycle proteins10,11. Cell proliferation initially involves cell cycle 
progression from G0-G1
12. Typically, this occurs through growth factor stimulated expression of cyclin D, which 
then binds to cyclin-dependent kinase (CDK) proteins, precipitating release of E2F transcription factors to drive 
cell cycle progression12–14. In many cell types, cyclin D-CDK complexes can also be inhibited by P27, creating a 
stable trimeric complex that maintains cell cycle arrest15. In the ovary, in contrast to other D-type cyclins, cyclin 
D2 (CCND2) mRNA is detectable in GCs of follicles across a range of stages and knockout of both cyclin D2 
(Ccnd2−/−) and p27−/− exhibit dis-regulated early follicle development with major efects on fertility16–18.
We therefore carried out detailed analysis of CCND2 and P27 in the context of arrested primordial and early 
developing follicles, focussing on the relationship of these factors with TGFβ signalling in GCs. Using the C57/Bl6 
 ?Academic Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabolism, University 
ƥǡƥǡ ? ? ?	ǡǤ ?Present address: Department of Obstetrics and Gynecology, 
McGill University Health Centre, Montreal, Canada.  ?Institute of Reproductive and Developmental Biology, Imperial 
ǡǡǡǡ ? ? ?ǡǤ ?Present address: 
Department of Surgery and Theriogenology, College of Veterinary Medicine, University of Mosul, Mosul, Iraq. 
Correspondence and requests for materials should be addressed to M.A.F. (email: ǤǤ ?ƥǤǤ )
Received: 29 January 2019
Accepted: 9 April 2019
Published: xx xx xxxx

2SCIENTIFIC REPORTS |          (2019) 9:6513  | ǣȀȀǤȀ ? ?Ǥ ? ? ? ?Ȁ ? ? ? ? ?Ǧ ? ? ?Ǧ ? ? ? ? ?Ǧ ?
www.nature.com/scientificreportswww.nature.com/scientificreports/
Figure 1. SMAD3 is predominantly expressed in GCs of primordial follicles. (A) Diagram showing the follicle 
composition of the prepubertal mouse ovary at 4, 8 and 12 days of age (d4, d8, d12). (B) Immunoluorescent 
localisation of SMAD2 and SMAD3 protein in the prepubertal mouse ovary. SMAD2 (green) was weak/
undetectable in prepubertal ovaries, including primordial (yellow arrow) and early growing primary follicles 
(yellow asterisk), but was strong in corporal lutea from adult ovary (d16 inset). SMAD3 (red) localised to 
the nuclei and cytoplasm of GCs of primordial and transitional follicles (arrows), with nuclear expression 
appearing weaker in GCs of growing primary-plus follicles (arrowheads). Cell nuclei are counterstained with 
DAPI (blue). Rabbit IgG is shown as a negative control. (C,D) Relative expression of Smad2 and Smad3 mRNA 
by qPCR in d4, d8 and d16 ovaries. (E–G) Quantitative analyses of SMAD3 immunoluorescence. (E) Data 
represents total SMAD3 staining intensity in GCs by follicle stage. Each point represents the % positive pixels 
in the GC compartment for an individual follicle. (F) Nuclear SMAD3 intensity in GCs by follicle stage. Each 
point represents the % positive pixels in individual GC nuclei within each follicle stage. Points in red and blue 
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mouse as a model, we show that SMAD3 speciically localises to GCs of small follicles where it directly promotes 
the expression of Ccnd2 and represses Myc. he CCND2 protein is detectable in complex with the inhibitory factor 
P27 and together highlights a mechanism that potentially maintains primordial GC arrest, whilst ensuring they are 
poised ready to proliferate. Interestingly, the loss of SMAD3 in GCs of growing follicles is associated with elevated 
mTOR signalling, potentially explaining a dual mechanism of TGFβ signalling in follicle growth and arrest.

 ?
Ǥ Both SMAD2 and SMAD3 medi-
ate TGFβ signalling and regulate gene expression10,11,19; however, whether both or either SMAD is important in 
this context is not known. In this study, we have used ovaries from C57/Bl6 mice at postnatal day 4, 8 and 16 as 
a natural developmental paradigm to analyse gene expression in primordial, early activated (transitional), and 
growing follicles (primary, primary+ , secondary), respectively20,21 (Fig. 1A). Immunoluorescent localisation of 
SMAD2 was very weak in ovaries at each age, while SMAD3 was speciically expressed in GCs of small follicles, 
notably in the earliest primordial stages as exempliied in sections from day 4 ovaries (Fig. 1B). Consistent with 
this, the level of Smad2 mRNA, although detectable, did not vary between the diferent ovary ages (Fig. 1C), 
whereas Smad3 mRNA expression was reduced in day 8 and 16 ovaries in which the relative proportion of pri-
mordial follicles is reduced (Fig. 1D). Based on these indings we focused on SMAD3 for further analyses.
When SMAD3 immunoluorescence intensity values were plotted by follicle stage, a bi-phasic pattern was 
evident, with total GC-expression being highest in transitional follicles that are poised to initiate growth, and 
lowest in more advanced secondary-staged growing follicles (Fig. 1E). Since SMAD3 is a cytoplasmic signalling 
mediator and nuclear transcription factor19,22, we analysed GC expression in both cellular compartments. In GC 
nuclei SMAD3 was highly variable; however, the median expression was similar between primordial, transitional 
and primary staged follicles, and was lower from the primary plus stage (Fig. 1F). Nuclear SMAD3 in each fol-
licle was then normalised against cytoplasmic expression to determine if the ratio was equal throughout follicle 
development. he results, however, show that SMAD3 was similarly located in the nuclei and cytoplasm of GCs in 
primordial and transitional follicles, with a relative reduction in nuclear expression from the primary stage, indi-
cating that nuclear exclusion occurs prior to the general loss of SMAD3 expression in GCs (Fig. 1G). Sub-cellular 
fractionation of protein lysates from day 4 ovaries further conirmed that SMAD3 was detectable in both nuclear 
and non-nuclear fractions (Fig. 1H). Since SMAD3 exhibits a DNA binding domain22, our indings support a role 
for SMAD3 as a potential transcriptional regulator in GCs of primordial follicles.
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
Ǥ he expression of D-type cyclins occurs early in the cell cycle12,15; therefore, the localisation and 
regulation of CCND2, as well as the inhibitory partner P27 in quiescent primordial follicles were investigated. 
CCND2 was detectable in GC and oocyte nuclei, with relatively strong staining evident in GCs of small, single 
layered follicles (Fig. 2A). Strong expression (intensity values >75%) of CCND2 was detectable in GCs of over 
50% of primordial follicles analysed, with a relative reduction in expression from the primary stage onwards 
(Fig. 2B). Consistent with this, Ccnd2 mRNA levels in whole ovaries were signiicantly reduced in older ovaries 
containing proportionately more growing follicles, relative to day 4 ovaries (Fig. 2C). As with CCND2, P27 pro-
tein localised to GC nuclei of small follicles (Fig. 2D). Staining was highly variable between primordial follicles; 
however, the nuclear expression of P27 signiicantly declined in the majority of growing follicles from the primary 
stage onwards (Fig. 2E). his loss of expression in developing follicles relected p27 mRNA expression in whole 
ovaries, which was signiicantly reduced in day 8 and 16 ovaries, relative to day 4 (Fig. 2F).
Both proteins co-localised in GC nuclei of small follicles regardless of age (Fig. 2G). We then focussed on 
d4 and d8 ovaries due to the preponderance of primordial and small activated follicles. Although the degree of 
co-localisation in each cell varied widely within follicles and between follicle stages, the ratio of P27 to CCND2 
declined from the transitional stage onwards. hus, as follicles activate, P27 is initially reduced while CCND2 
persists (Fig. 2H). In support of this, both CCND2 and P27 co-immunoprecipitated in protein lysates from day 
4 ovaries. However, in day 16 ovaries, although CCND2 was detectable by western blot, the same protein was 
beyond the limits of detection by western blotting following immunoprecipitation with P27 (Fig. 2I). Together 
these data indicate that CCND2 and P27 exist in molecular complexes in GCs of primordial follicles. Consistent 
with a role for P27 as a cell-cycle inhibitory factor15, it is likely that P27 is inhibiting the activity of CCND2 in 
primordial GCs, thereby participating in maintaining the quiescent phenotype of primordial follicles.
 ?͸MycǤ Since the transcrip-
tion factor SMAD3 is expressed in GC nuclei of primordial/transitional follicles alongside CCND2 and P27, we 
represent measurements from d4 and d8 ovaries, respectively. (G) Nuclear/cytoplasmic ratio of SMAD3 in GCs 
by follicle stage. Each point represents the % positive pixels in all GC nuclei relative to % positive pixels in the GC 
compartment for an individual follicle obtained from d8 ovaries. Dashed lines (E,F) demarcate lower and upper 
quartiles to represent proportions of samples that were considered low, medium and high intensity staining, 
respectively. (H) Subcellular expression of SMAD3 by western blotting in protein lysates from d4 mouse ovaries. 
Samples were separated into cytosolic, membrane-bound organelle, and nuclear fractions. he cytoplasmic 
protein GAPDH is included as a control. Gel images have been cropped from originals provided in Fig. S1. PF, 
primordial; T, transitional; P, primary; P + , primary plus, S, secondary follicle. Data in C, D are means ± SEM 
(n = 5 ovaries/age) and diferences are relative to d4. Data in E, F, G are medians ± interquartile ranges and 
diferences are relative to the follicle stage in parentheses. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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Figure 2. CCND2 and P27 are maintained in GCs of primordial follicles but decrease as follicles initiate growth. 
(A) Immunoluorescent localisation of CCND2 (red) in the prepubertal mouse ovary. High power images show 
strong (persistent) nuclear CCND2 staining in GCs of primordial follicles (PF; arrows). Transitional follicles (T) 
show nuclei with variable CCND2 (arrow heads) whereas larger primary plus staged follicles (P+) show weak 
CCND2 expression. (B) Nuclear CCND2 protein expression in GCs by follicle stage. Each point represents the % 
positive pixels for all GC nuclei in an individual follicle. (C) Relative expression of Ccnd2 mRNA by qPCR in d4, d8 
and d16 ovaries. (D) Immunoluorescent localisation of P27 (green) in the prepubertal mouse ovary. High power 
images (lower panels) show strong nuclear P27 staining in GCs of primordial follicles (PF; arrows). Transitional 
follicles (T) show nuclei with variable P27 whereas larger secondary staged follicles (S) show weak P27 expression. 
(E) Nuclear P27 protein expression in GCs by follicle stage. Each point represents the % positive pixels for all GC 
nuclei in an individual follicle. (F) Relative expression of p27 mRNA by qPCR in d4, d8 and d16 ovaries. (G) Co-
localisation of CCND2 and P27 in the prepubertal mouse ovary. Ater image processing (d4 and d8; lower panels), 
only positive pixels in the green and red channels are shown, highlighting co-localisation in white. A negative 
IgG control (d16; lower right) is shown. (H) P27/CCND2 ratio in individual GCs by follicle stage. Each point 
represents the % positive pixels for P27 relative to % positive pixels for CCND2 an individual nucleus. Numbers 
in parentheses refer to the GC number range for each follicle stage. (I) Western blot of P27 and CCND2 following 
co-immunoprecipitation from d4 and d16 ovaries. Protein samples (12.5 µg) were immunoprecipitated using anti- 
P27 (IP) or non-speciic rabbit IgG (IgG; control). Non-immunoprecipitated protein (5 µg) was used as positive 
control (IN). Gel images have been cropped from originals provided in Fig. S2. PF, primordial; T, transitional; P, 
primary; P+, primary plus, S, secondary follicle. Nuclei in A, D, G are labelled with DAPI (blue). Data in B, E, H are 
medians ± interquartile ranges and diferences are relative to the follicle stage in parentheses. Points in red and blue 
represent measurements from d4 and d8 ovaries, respectively. Data in C, F are means ± SEM (n = 5 ovaries/age) 
and diferences are relative to d4. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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then investigated whether SMAD3 has the ability to directly bind and regulate the expression of Ccnd2 and p27 
in this context. he immediate early gene Myc was also used as a positive control, since it is a well-known target 
of SMAD3 and is involved in cell-cycle progression7–9. In day 4 and day 16 ovaries, SMAD3 was detected on the 
promoter of Ccnd2 using ChIP-PCR, which was signiicant when quantiied in relation to non-immune control 
IgG (Fig. 3A). his is consistent with the observed reduction in Ccnd2 gene expression in ovaries of Smad3−/− 
mice23,24. SMAD3 was also detectable on the promoter of the Myc gene in day 4 ovary samples; however, this bind-
ing was not signiicantly diferent from control IgG in day 16 ovary samples (Fig. 3B). By comparison, SMAD3 
binding to the p27 promoter was undetectable by ChIP-PCR in day 4 ovaries, and barely detectable in day 16 
ovaries (Fig. 3C). herefore, it is unlikely that p27 is a direct target of SMAD3 in small follicles.
Since Myc has a well-ascribed role in promoting cell proliferation25,26, we then quantiied expression in imma-
ture ovaries. he increase in Myc mRNA expression in day 8 and day 16 ovaries relative to day 4 ovaries (Fig. 3D) 
suggests that SMAD3 acts to repress Myc transcription in primordial follicles. Conversely, the decrease in Ccnd2 
mRNA expression in day 16 ovaries relative to day 4 ovaries observed previously (Fig. 2A–C) shows that SMAD3 
likely promotes cyclin D2 expression in primordial follicles. hese indings imply that TGFβ-SMAD3 signalling 
acts directly on GCs of primordial follicles to diferentially regulate genes involved in cell cycle regulation.

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Considering the above observations, we then investigated the efect of an altered TGFβ environment on small 
follicle development in vitro. Previous studies have shown that long-term culture of neonatal rodent ovaries 
( > 7 days) with a TGFβ ligand can inluence primordial follicle viability27–29. In cell culture models, changes in 
SMAD3-regulated gene expression have been observed as little as 30 minutes ater stimulation with TGFβ lig-
ands30,31. Furthermore, a 60–90 min exposure of kit ligand or the pathway inhibitor imatinib to post-natal day 7 
mouse ovaries in culture was suicient to cause a signiicant shit in FOXO3a translocation in oocytes32. We there-
fore evaluated efects on gene expression and signalling following a brief 2-hour exposure to TGFβ1 ligand and 
A83-01, a Type I receptor inhibitor, in day 4 ovaries in vitro. Consistent with in vivo indings, SMAD3 bound to 
the promoter of Ccnd2 and Myc in unstimulated (control) ovaries. By comparison, binding to Ccnd2 and Myc was 
no longer evident in ovaries exposed to either TGFβ1, A83-01, or a combination of TGFβ1 and A83-01 (Fig. 4A), 
indicating that modulation of TGFβ signalling causes dissociation of SMAD3 from the promoters of these genes. 
Moreover, dissociation of SMAD3 to target gene promoters was not able to be over-ridden by exposure to TGFβ1. 
Interestingly, this change in binding was associated with elevated expression of the pro-proliferation factor Myc 
in ovaries exposed to TGFβ1. Myc is an early response gene and in other studies Myc mRNA reaches maxi-
mum levels ater 2–3 hours ater growth factor stimulation, whereas induction of Ccnd2 mRNA peaks around 
4 hours33,34. he latter point may explain why the loss of SMAD3 occupancy on the Ccnd2 promoter did not 
efect Ccnd2 mRNA expression in the same way as Myc (Fig. 4B). Elevated transcript levels of Smad7 – a negative 
regulator of TGFβ signalling35,36 were also observed, suggesting one efect of increased exposure to TGFβ1 is to 
Figure 3. SMAD3 directly regulates Ccnd2 and Myc expression in primordial follicles. (A–C) Ampliication 
of target binding sites upstream of the Ccnd2, Myc and p27 genes following ChIP. Representative gel images 
showing ampliication of DNA ater immuno-precipitation with anti-SMAD3, anti-FOXL2 (GC expressed 
transcription factor – control), or non-speciic antibodies (IgG) in d4 and d16 mouse ovaries. A positive sample 
of chromatin (Input) prior to immunoprecipitation is also shown (upper panels). Relative quantiication of anti-
SMAD3 IgG binding to Ccnd2 (lower panel A) and Myc (lower panel B) gene promoters in d4 and d16 ovaries 
by qPCR. % input was calculated by normalizing anti-SMAD3 IgG and non-speciic IgG (control) against input 
DNA as described in the materials and methods. Each group (d4, d16) contained 5 repeats (n = 5 ovaries). 
Data are medians ± interquartile range and statistical diferences are relative to IgG control. *P < 0.05, NS: Not 
signiicant. Note the Ccnd2 gel is a composite as indicated with divisional space and all gel images have been 
cropped from originals provided in Fig. S3. (D) Relative expression of Myc mRNA by qPCR in d4, d8 and d16 
ovaries. Means ± SEM (n = 5 ovaries/age) and diferences are relative to d4. *P < 0.05, ****P < 0.0001.
6SCIENTIFIC REPORTS |          (2019) 9:6513  | ǣȀȀǤȀ ? ?Ǥ ? ? ? ?Ȁ ? ? ? ? ?Ǧ ? ? ?Ǧ ? ? ? ? ?Ǧ ?
www.nature.com/scientificreportswww.nature.com/scientificreports/
Figure 4. Short term exposure to TGFβ1 promotes mTOR signalling in neonatal mouse ovaries. Whole 
neonatal mouse ovaries (d4) were maintained in vitro and exposed for 2 hours in either 1 µM DMSO 
(control; C), 10 ng/ml of TGFβ1 ligand (T), or 1 µM A83-01 inhibitor (I). An additional group was exposed 
to 1 µM A83-01 inhibitor followed by 10 ng/ml of TGFβ1 ligand (IT). Ovaries were analysed for gene and 
protein analysis immediately following treatment. (A) Relative quantification of SMAD3 binding to Ccnd2 
and Myc gene promoters in cultured ovaries by ChIP-qPCR. Each group contained 5 ovaries (n = 5). Data 
are medians ± interquartile range and statistical differences are relative to IgG control (*P < 0.05). (B) 
Relative expression of Myc, Smad7 and Ccnd2 mRNA in cultured ovaries. Each group contained 5 ovaries 
(n = 5). Data are means ± SEM; *P < 0.05 vs group indicated in parentheses. (C) Expression of phospho-
intermediates in the canonical TGFβ (p-SMAD3), PI3 kinase/Akt (p-AKT), p44/42 MAPK (p-ERK1/2) 
and mTOR (p-S6) pathways in cultured ovaries by western blot. Example blots are shown (left-hand 
panels; originals provided in Fig. S4) and levels quantified by normalization against beta-actin (loading 
control). Data represents four samples from each group, each from an independent blot. *P < 0.05 vs 
group indicated in parentheses.
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inhibit the action of SMAD3 (Fig. 4B). In ovaries exposed to A83-01 or a combination of TGFβ1 and A83-01, Myc 
expression was unchanged. As Myc is normally repressed in cells with low turnover, it is possible that other tran-
scriptional repressors independent of TGFβ signalling, such as WT137,38, are active in primordial GCs, although 
further studies would be required to conirm this.
Since exposure to A83-01 and TGFβ1 led to a similar loss of SMAD3 promoter binding, but with diferential 
efects on Myc and Smad7 expression, we sought to determine if this was associated with elevated SMAD3 sig-
nalling, or activation of SMAD-independent pathways. Levels of p-SMAD3, p-AKT and p-ERK1/2 proteins did 
not vary between TGFβ1, A83-01 or control groups. By comparison, the mTOR mediator p-S6 was signiicantly 
increased in ovaries exposed to TGFβ1 in comparison to ovaries exposed to A83-01 or control (Fig. 4C), indicat-
ing that elevated TGFβ signalling in neonatal ovaries leads to early efects on the mTOR pathway.

	βǦƤơǤ 
Finally, in order to evaluate the consequence of an acutely altered TGFβ environment, ovaries were returned 
to control media for an additional two days. Processed ovaries were then stained with SMAD3 and DDX4 as 
markers of the GC compartment and oocytes, respectively, for morphological assessment and quantiication. 
he overall distribution of follicles was similar between groups, although GCs of growing primary follicles in 
ovaries exposed to A83-01 had failed to adequately cuboidalise (Fig. 5A). When follicles were classiied according 
to oocyte size, TGFβ1 or A83-01 had no efect on stage of follicle development (Fig. 5B). Likewise, exposure to 
TGFβ1 or A83-01 had no efect on oocyte size (Fig. 5C). Interestingly, brief exposure to TGFβ1 ligand promoted 
a small, but measurable increase in the mean GC number of follicles classiied as primordial, suggesting that 
Figure 5. Acute modulation of TGFβ signalling causes stage-speciic efects on follicle development. Whole 
neonatal mouse ovaries (d4) were maintained in vitro and exposed for 2 hours with either 10 ng/ml of TGFβ1 
ligand (T), 1 µM A83-01 inhibitor (I), or 1 µM DMSO (C). Ovaries were then placed in basic culture media 
for two additional days prior to morphological analysis. (A) Confocal images of sections of cultured ovaries 
immunolabelled with DDX4 (red) and SMAD3 (green) to highlight oocytes and GCs, respectively. Cell nuclei 
are counterstained with DAPI (blue). Low power images (upper panels) showing general distribution of follicles 
in each group. Scale bars = 100 µm. High power images (lower panels) showing examples of early growing 
primary (P) and primary plus (P+) follicles in each group as classiied by oocyte size. Note the smaller size 
of the GC-layer in follicles exposed to the inhibitor. Scale bars = 20 µm. (B) Proportion of follicles classiied 
by follicle stage. (C) Distribution of oocyte size by treatment. (D) Mean GC number per follicle. Quantitative 
data from cultured ovaries (B–D) was obtained from six diferent ovary sections per treatment group (n = 6 
ovaries/group). Classiication was based on oocyte size (Fig. S5). Data show means ± 95% CI. *P < 0.05 and 
****P < 0.0001 vs control. PF, primordial; T, transitional; P, primary; P+, primary plus follicle.
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2 hours of elevated TGFβ1 was suicient to promote GC proliferation but not suicient enough to promote signif-
icant oocyte growth. By comparison, exposure to A83-01 had no efect on GCs of primordial follicles but caused 
a signiicant reduction in mean GC number in follicles classiied as growing, indicating that inhibition of TGFβ 
receptors inhibits normal GC proliferation in activated follicles (Fig. 5D). It should also be noted that very few 
apoptotic cells were detectable in any of the groups as determined by TUNEL labelling (Fig. S6). he reduction in 
GC number along with inadequate cuboidalisation indicates that inhibition of TGFβ receptors likely impairs nor-
mal GC proliferation in activated follicles. hus, although SMAD3 is reduced in GCs of growing follicles (Fig. 1), 
TGFβ signalling is still essential, which is consistent with the well-ascribed role of other TGFβ ligands that signal 
through the same Type I receptors, such as GDF939–42 and activin43–46 in supporting early follicle development.

he ovarian reserve consists of a limited pool of primordial follicles held in a state of developmental arrest1,3–5. 
he molecular programme that maintains this arrest, and conversely regulates activation and growth is largely 
unknown. We recently presented a detailed analysis highlighting an inverse relationship between nuclear 
SMAD2/3 expression and cell proliferation in GCs of mouse ovaries, suggesting a role for TGFβ signalling in pri-
mordial follicle maintenance and activation6. Here, we show that SMAD3 recapitulates the pattern of SMAD2/3 
and is associated with expression of the cell cycle regulators cyclin D2 and P27. he speciic localisation of these 
proteins was similar in ovaries derived from d4 and d8 mice, each with diferent populations of developing 
follicles, further highlighting a stage-speciic, rather than age-dependent role in in GCs of non-growing and 
early growing follicles (Fig. S7). In non-growing follicles, it is unlikely that SMAD3 directly regulates P27 in this 
context; instead, SMAD3 binds directly to Ccnd2 and Myc to diferentially regulate these genes, which may be 
important for ensuring GCs are ‘poised’ in a state ready to progress through the cell cycle. he presence and accu-
mulation of CCND2 in complex with P27 suggests a mechanism for primordial follicle maintenance, where P27 
may prevent GC cycle progression by inhibiting cyclin-CDK activity15. his hypothesis is consistent with other 
studies reporting an inhibitory efect of P27 on early follicle activation16,47. Although the mechanism leading to a 
reduction in P27 activity in this context is currently unknown, it is clear that follicle growth is also associated with 
a reduction in accumulated CCND2 and SMAD3 – the latter also allowing de-repression of Myc. CCND2 and 
SMAD3 are important regulators of the cell cycle and although their steady-state expression is reduced in growing 
follicles, both proteins are still expressed at a moderate level in GCs (Figs 1 and 2). Furthermore, briely exposing 
ovaries to an elevated environment of TGFβ led to a slight increase in GC proliferation. his occurred following 
an immediate uncoupling of SMAD3 from Ccnd2 and Myc gene promoters alongside elevated mTOR signalling. 
Activation of mTOR signalling in primordial GCs is a key early event in follicle initiation48, has been implicated 
in TGFβ-driven models of epithelilal-mesenchymal transition49, and plays an important role more generally in 
cellular growth and proliferation50.
Figure 6. Model of cell cycle regulation in GCs of small follicles. Arrested GCs of primordial follicles express 
the transcription factor SMAD3, which directly promotes expression of CCND2 and represses Myc. In this 
‘poised’ state, CCND2 is bound by the inhibitory factor P27. In transitional GCs, P27 dissociates from CCND2 
and SMAD3 expression transiently increases, possibly via elevated TGFβ signalling, allowing maintenance of 
CCND2 expression for cell cycle progression. Increased SMAD3 promotes expression of factors such as Smad7, 
which act to inhibit SMAD3 in a self-regulatory manner. he eventual loss of SMAD3 leads to de-repression 
of Myc and activation of SMAD-independent TGFβ signalling involving mTOR to drive GC proliferation in 
growing follicles. Solid black line arrows indicate predominant signalling pathway. Coloured block arrows 
indicate moderate (unilled arrows) or substantial (illed arrows) changes in expression relative to primordial 
stage. Note in growing follicles, although SMAD3 and CCND2 are reduced, they are still detectable and play an 
essential role in regulation of the GC cycle. PF, primordial; T, transitional; P, primary follicle.
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Based on these indings, we propose a multi-step mechanism of follicle activation that initially involves a basal 
level of SMAD3 expression and nuclear activity to prepare GCs for proliferation. It remains to be determined 
whether this activity in primordial GCs is dependent on receptor-mediated signalling, and if so, which is the 
principle ligand involved; however, increased TGFβ1 ligand exposure promotes a shit to a SMAD-independent 
pathway, which drives cell proliferation and eventual follicle activation (Fig. 6). he role of other TGFβ superfam-
ily members and the cross-talk involved in regulating SMAD signalling in this context will also be important to 
establish. Although this study has used the mouse as a model organism, revelation of the molecular framework 
that underscores the phenotype of pre-granulosa cells in other species is essential for understanding how the 
ovarian reserve is maintained throughout the reproductive lifetime of the female.

Ǥ All ovary tissues used in this study were obtained from wild-type C57Bl6 
mice housed in the Biological Services Unit at the University of Sheffield in compliance with the Animals 
(Scientiic Procedures) Act, 1986. Mice were killed by a registered practitioner (Schedule 1 procedures) with 
approval from the University of Sheield Training and Competency Oicer. For total RNA, protein extraction 
and ChIP experiments, ovaries from immature mice (day 4, 8 and 16) were dissected and either placed in culture 
(day 4 only) or snap frozen in liquid nitrogen and stored at −80 °C. For immunostaining, ovaries were immersed 
in 10% neutral bufered formalin solution (Sigma-Aldrich) for 24 hours and processed in parain blocks and 
sectioned at 5 µm.
Ǥ Ovaries were placed in 24 mm Transwell plates containing membrane 
inserts (Corning; Sigma). Culture medium consisted of Waymouth medium 752/1 (Life Technologies) supple-
mented with 10% fetal bovine serum (FBS; Sigma), 0.23 mM pyruvic acid (Sigma), 10 µg/ml streptomycin sul-
fate (Sigma), 75 µg/ml penicillin G (PENK; Sigma) and 0.3 mg/mL BSA. Ovaries were maintained in a 37 °C 
incubator (5% CO2) for 24 h prior to any treatment. For the assessment of the molecular changes under difer-
ent TGFβ conditions (SMAD3 binding and gene regulation) ovaries were exposed for 2 h in serum free culture 
media, supplemented with either TGFβ1 ligand (10 ng/ml; R&D systems, 240-B-002), A83-01 (1 µM; MedChem 
Press, 2939), a selective inhibitor of Type 1 TGFβ receptors ALK4, ALK5 and ALK751, a combination of TGFβ1 
(10 ng/ml) and A83-01 (1 µM), or DMSO (control; same volume as for A83-01; Sigma). A single time point 
(2 hours) and concentration for TGFβ1 ligand (10 ng/ml) and A 83-01 inhibitor (1 µM) were selected based on 
previous studies27–29,51,52. Immediately following treatment, ovaries were collected and either ixed and processed 
for ChIP-qPCR or lash frozen in liquid nitrogen for gene expression analysis. For the assessment of the morpho-
logical changes, ovaries were exposed for 2 h in serum free culture media followed by supplementation as above. 
In the TGFβ1 treatment group, the addition of A83-01 inhibitor for an extra 1 hour was used to block further 
TGFβ1 signalling as previously described53. Treatments were then washed out and ovaries were let in culture for 
two days before processing.
Ǥ Sections were dewaxed before microwaving in 0.1 M citrate buffer 
(pH6.0). Sections were blocked with CAS universal blocking reagent (hermoFisher) for 20 minutes at room tem-
perature to reduce non-speciic binding. Speciic antibodies against SMAD2 (0.59 µg/ml, #5339, Cell Signaling 
Technology, MA, USA), SMAD3 (0.75 µg/ml, #9523, Cell Signaling), SMAD2/3 (0.25 µg/ml, 133098, Santa Cruz 
Biotechnology, TX, USA), CCND2 (0.5 µg/ml, sc-593, Santa Cruz Biotechnology, TX, USA), DDX4 (2.2 µg/ml, 
ab13840, Abcam, Cambridge, UK) and P27 (1 µg/ml, sc-528, Santa Cruz or 0.5 µg/ml, sc-1641 for co-localisation) 
were diluted in blocking solution and incubated overnight at 4 °C. A species-speciic isotype control IgG antibody 
at the same concentration (normal rabbit IgG I-1000 and normal mouse IgG I-200, Vector Laboratories) were 
included in each experiment. Sections were washed in PBS and incubated with secondary antibodies (either 
donkey anti-rabbit AlexaFluor® 488 or AlexaFluor® 555; donkey anti-mouse AlexaFluor® 488 and AlexaFluor® 
555, each 1:400; Invitrogen). Sections were mounted with a drop of Prolong® Gold anti-fade reagent with DAPI 
(ThermoFisher) and were imaged using an inverted Leica SP5 confocal laser-scanning microscope (Leica 
Microsystems, Wetzlar, Germany).
Ǥ Quantification of GC factors in situ 
was performed from a total of 7 ovaries (four day 4 and three day 8 ovaries) using the largest cross section per 
ovary. Confocal images were stitched together using DoubleTake (http://echoone.com/doubletake/) to create a 
high-resolution composite of each section. Images were obtained as an 8-bit RGB stack ile and the threshold 
for each channel in every composite section was set up with the same criteria across the diferent sections of the 
same staining. Pixels above the threshold were considered as ‘positive pixels” while the remaining pixels were 
registered as negative. he oocyte cytoplasm was used as a baseline setting (due to lack of speciic staining) and 
threshold settings were normalised against this to account for variation between slides. Follicles with a visible 
oocyte nucleus were selected with the region of interest (ROI) manager tool of ImageJ sotware (https://imagej.
nih.gov/ij/). In order to quantify each of the candidate proteins in diferent ROIs, the area of positive pixels “Area 
fraction” was calculated and referred as “Intensity” for simplicity. ROIs from each follicle were selected manually 
using the DAPI channel and the “measure and label” tool, which allowed the intensity of each ROI in either the 
green or red channel to be quantiied. Follicles were classiied by the number of GCs and oocyte area (Fig. S5). 
For each follicle, measurements were recorded for the intensities of individual GC nuclei. For SMAD3 analysis, 
the intensity of the entire GC compartment was also measured and the ratio between the geometric mean of 
the intensities for the GC nuclei, and the geometric mean for the entire GC compartment were calculated and 
plotted as a measure of nuclear:cytoplasm expression. CCND2 and P27 co-localisation was analysed with the 
“Colocalization threshold” plugin from ImageJ. A minimum of 20 individual GC nuclei from primordial and 
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transitional follicles were selected from a single day 4 and day 8 ovary section. he ratio of intensities between 
CCND2 and p27 was represented as (P27/CCND2). For cultured ovaries, sections were stained with antibodies 
against DDX4 and SMAD3 and image analysis was performed as described above. When more than one section 
from the same ovary was used, a minimum separation of 2 sections (10 µm) from the largest cross-section was 
considered to avoid double counting.

Ǥ Total RNA was isolated from ovaries using RNeasy® Micro Kits (QIAGEN, 
Crawley, UK). Concentration and purity of all RNA samples was assessed using the Agilent 2100 Bioanalyzer. 
Samples with an RNA integrity number (RIN) between 8 and 10 were used for gene expression analysis. Fity ng 
of RNA from each sample was converted to cDNA using the SuperScript III Reverse Transcription kit (Invitrogen; 
hermoFisher). Quantivative PCR (qPCR) using 500 nM of primers for Smad2, Smad3, Smad7, Myc, Ccnd2 and 
p27 (Table S1) were used with the SensiFAST™ SYBR® Hi-ROX kit (Bioline). Eiciencies were 90–130% for all 
primers. Samples (1 µl per reaction) and the same volume of distilled water (negative control) were run in dupli-
cate in 384 well-plates. qPCR conditions were as follows: activation at 95 °C for 2 minutes and then 40 cycles of 
ampliication (3 seconds at 95 °C for DNA denaturation, 20 seconds at 60 °C for primer annealing and 10 seconds 
at 72 °C for primer extension) using a 7900HT Fast Real-Time PCR System (Applied Biosystems). Ct values were 
normalised against Atpb5 (PrimerDesign, Southampton, UK) as previously described6,21 and fold changes (rela-
tive to control sample) were calculated for each gene according to the 2−∆∆Ct method54.
Ǥ Protein extraction from whole ovaries was performed ater ini-
tial disruption with 25 G needles with Pierce IP lysis bufer (hermo Fisher Scientiic) containing protease inhibi-
tors (cOmpleteTM Mini ULTRA tablets; Roche) and phosphatase inhibitors (PhosSTOPTM, Roche). Pooled ovaries 
(3) from day 4 and 16 mice were used for co-immunoprecipitation or (2) for processing cultured ovaries. Samples 
were vortexed, centrifuged and concentration of supernatant was measured using the Pierce bicinchoninic acid 
(BCA) protein assay kit (hermoFisher). For subcellular fractionation, proteins were extracted from six day 4 
mouse ovaries using a sequential lysis protocol as described previously55. his protocol utilises a gradient of deter-
gent lysis bufers to sequentially yield a cytosolic fraction, a membrane-bound organelle fraction and a nuclear 
fraction, respectively. Equal amounts (3–5 µg) of the cytosolic, organelle and nuclear protein fractions were used 
for analysis by western blotting.
ǦǤ Twenty-five µg of total protein was diluted with 
Pierce IP lysis bufer (hermoFisher Scientiic) and 2 µg of the immunoprecipitating antibody P27 (sc-528, 
Santa Cruz) were incubated for 1.5 hours at 4 °C with rotation. he same amount of protein was used to incubate 
with a non-speciic IgG (Normal rabbit IgG I-1000, Vector Laboratories). 20 µl of Protein G magnetic beads 
(Merck-Millipore, MA, USA) were added to each aliquot and incubated with rotation for an additional hour. 
Bead/protein complexes were washed with IP bufer and gentle centrifugation. Ater the last wash, 35 µl of 5x 
loading bufer (EC-887, National Diagnostics, GA, USA) was used to elute the beads. Half of the volume of the 
IP samples was loaded on the western blot, and input samples (control for the IP) contained 20% of the initial 
amount of protein used for the IPs. Proteins were separated in 12% separating gel and 4% stacking PAGE gels. 
Proteins were transferred to a nitrocellulose membrane using a semi-dry transfer. Membranes were washed with 
TBS-Tween and blocked in either 5% (w/v) BSA (Sigma) for phospho-protein detection or 5% (w/v) non-fat 
dried milk at room temperature for 2 hours. Blots were washed in TBS-Tween before applying primary antibodies 
for CCND2 (0.4 µg/ml; sc-593, Santa Cruz), P27 (0.6 µg/ml; sc-528, Santa Cruz), p-SMAD3 (1:1000; ab52903, 
Abcam), p-AKT (1:1000; 4060, Cell Signaling), p-ERK1/2 (1:1000; 4370, Cell Signaling), p-S6 (1:1000; 2211, Cell 
Signaling) overnight at 4 °C. Antibodies were detected using HRP-conjugated secondary antibodies (1:20,000; 
P0448, DAKO) and ECL reagents (Westar Supernova enhanced chemiluminescent HRP substrate; Cyanagen, 
Bologna, Italy).
ȋȌǦǤ Whole ovaries were ixed with 1% formaldehyde 
(Sigma) in Leibovitz’s L-15 medium (Life Technologies) for 30 minutes. An EZ- Magna ChIPTM G kit (Millipore) 
was used according to manufacturer’s instructions for the preparation of nuclear extracts and subsequent ChIP. 
2% of the initial volume was taken as control for the IPs (Input). Protein G magnetic beads (Merck-Millipore) 
were added to each aliquot along with 1 µg of immunoprecipitating antibody against SMAD2/3 (sc-133098, Santa 
Cruz) and non-immune mouse IgG (I-200, Vector Laboratories). As a positive control, an antibody against the 
protein FOXL2 was used (0.2 µg/ml; sc-55655, Santa Cruz), since Ccnd2 and p27 are known targets of this pro-
tein56,57. An equal volume (4 µl) of IP sample, control or RNAse/DNAse free water (additional negative control) 
were analysed by qPCR in duplicate using primers designed to lank predicted FOXL2, SMAD3 and MYC binding 
sites (TRANSFAC; Table S1) in 384 well-plates as described above. Input, IPs and IgG control samples were ana-
lysed using the ‘% input’ method where the mean Ct value of each IP and IgG sample was normalised against the 
input sample. Since the starting input sample was 2% of the initial chromatin, a dilution factor of 50 or 5.64 cycles 
(log 2 of 50) was subtracted and calculations were performed as follows: i) Mean Ct INPUT – 5.64, ii) Mean Ct IP 
(or IgG) - Mean Ct INPUT = ∆Ct, iii)% INPUT = (2 (−∆Ct)) × 100.
Ǥ For immunofluorescent quantification of SMAD3, CCND2 and P27, follicle 
stage-speciic diferences in expression were analysed using a non-parametric Kruskal-Wallis test with a post-hoc 
Dunn’s multiple comparisons test. For all gene expression analyses by qPCR, fold changes between groups were 
evaluated using one-way ANOVAs with post-hoc Bonferroni multiple comparisons tests. For the ChIP-qPCR 
data, non-parametric Mann-Whitney U tests were used to compare % input values in SMAD3 vs IgG control 
groups. Western blot data was analysed using one-way ANOVAs with post-hoc Tukey’s multiple comparisons 
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tests. Efect of diferent culture conditions on oocyte size was evaluated using a Kruskal-Wallis test with post-hoc 
Dunn’s multiple comparisons. All analyses were carried out using Prism (v7.03; Graphpad). Diferences were 
considered signiicant when P < 0.05.

All data generated or analysed during this study are included in this published article (and its Supplementary 
Information iles).
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